Most American households’ cash and savings are shrinking, SF Fed report says
@theconversation.com3 years ago
We still need a vaccine patent waiver, but not the one on offer at the World Trade Organization meeting
@theatlantic.com3 years ago
Did We Forget What School Is For?
@WSJ3 years ago
Promising drugs to treat Covid-19 are getting closer in the U.S., but supplies to low- and middle-income countries remain months away on.wsj.com
@forbes.com3 years ago
New Hurdle In The Race To Vaccinate The World: A Syringe Shortage
@WSJ3 years ago
Merck will license its Covid-19 antiviral pill to a U.N.-backed group to expand the drug's availability to low- and middle-income countries on.wsj.com
@abcnews.go.com4 years ago
Vaccine makers pledge 2.3B doses to less wealthy nations
@snopes.com4 years ago
AstraZeneca Confirms Strong Vaccine Protection After US Rift
@aljazeera.com4 years ago
Will poorer nations miss out on COVID-19 vaccine?
@rt.com4 years ago
UNICEF planning ‘mammoth operation’ to deliver 2 billion Covid-19 vaccines to 92 low-middle income countries in 2021
@forbes.com5 years ago
Pay People To Take The Covid-19 Vaccine? Lessons From International Development
@nytimesworld5 years ago
A prominent British laboratory is forming a special partnership that would sidestep the drug industry to sell a potential vaccine against the coronavirus without profits or licensing fees in Britain and in low- and middle-income countries nyti.ms
@axios.coma year ago
Countries debate drugmaker requirements in final pandemic treaty talks
@theconversation.com3 years ago
Politics with Michelle Grattan: Josh Frydenberg is optimistic about wage growth
@forbes.com3 years ago
Moderna Aims To Make Vaccines Against 15 Deadly Diseases—And The Next Pandemic
@WSJ3 years ago
Promising drugs to treat Covid-19 are getting closer in the U.S., but supplies to low- and middle-income countries remain months away on.wsj.com
@aljazeera.com3 years ago
WHO grants emergency approval for India’s Covaxin COVID-19 jab
@forbes.com3 years ago
Moderna Plans To Build Vaccine Factory In Africa, What This Means For Covid-19
@WSJ4 years ago
The center of the global Covid-19 pandemic has shifted decisively to low- and middle- income countries, fueling sickness and death on a scale that trends suggest could quickly exceed the world-wide toll in 2020 on.wsj.com
@jezebel.com4 years ago
Without Support From Wealthy Nations, People In Poorer Nations May Not Be Vaccinated Until 2023
@WSJ4 years ago
South Africa will start rolling out Covid-19 vaccines without requiring local regulatory approval of the shots, a step that other low- and middle-income countries are expected to follow on.wsj.com
@forbes.com4 years ago
Bill And Melinda Gates Are Giving $70 Million More For Covid Vaccines
@telegraph.co.uk5 years ago
Michelle Obama reveals she has 'low-grade-depression' due to coronavirus and Trump administration
@nytimesworld5 years ago
A prominent British laboratory is forming a special partnership that would sidestep the drug industry to sell a potential vaccine against the coronavirus without profits or licensing fees in Britain and in low- and middle-income countries nyti.ms
@qz.com2 years ago
WHO approves generic Paxlovid drug for covid treatment in low-income countries
@WSJ3 years ago
Pfizer has a deal to sell to Unicef the company’s Covid-19 pill Paxlovid. Unicef plans to provide it to 95 low- and middle-income countries on.wsj.com
@politico.com3 years ago
Moderna says it will 'never' enforce Covid-19 vaccine patents in dozens of low- and middle-income countries
@theconversation.com3 years ago
Supplying COVID-19 pills at lower cost is only part of what poorer countries need
@aljazeera.com3 years ago
Merck strikes deal for global access to COVID-19 medication
@WSJ3 years ago
Moderna, which has faced criticism for not supplying more Covid-19 vaccine doses to middle- and low-income countries, plans to build a $500 million plant in Africa on.wsj.com
@theguardian.com4 years ago
Act now to prevent oxygen shortage in Covid-hit countries, say campaigners
@forbes.com4 years ago
WHO Approves Johnson & Johnson’s Covid Vaccine As Developing Countries Lag In Immunizations
@qz.com4 years ago
Covid-19 further exposes inequalities in the global financial system
@forbes.com4 years ago
Rich Countries Reserve Billions Of Covid-19 Vaccine Doses Even Before There Is One
@forbes.com5 years ago
Working With Other Countries To Fight The Coronavirus Pandemic Protects America’s National Interests
@nytimesworld5 years ago
A prominent British laboratory is forming a special partnership that would sidestep the drug industry to sell a potential vaccine against the coronavirus without profits or licensing fees in Britain and in low- and middle-income countries nyti.ms
@forbes.com2 years ago
Air Arabia Profits Double, As Low-Cost Airlines Lead Recovery In Middle East Aviation
@forbes.com3 years ago
Pfizer Signs Deal With UNICEF To Distribute Its Covid Antiviral Drug
@forbes.com3 years ago
Covid-19 In The Middle East: How Qatar Is Fighting Omicron
@WSJ3 years ago
Pfizer is licensing its experimental Covid-19 antiviral to a global health organization in an effort to make the pill more readily available to people in low- and middle-income countries. on.wsj.com
@aljazeera.com3 years ago
Merck strikes deal for global access to COVID-19 medication
@qz.com4 years ago
Thailand, battling a third wave, is opening Phuket to quarantine-free tourism
@abc.net.au4 years ago
Wealthy countries 'are buying up far more vaccines than they need' — and that's bad news for the end of the pandemic
@abc.net.au4 years ago
'Momentous occasion': Ghana first nation to receive free COVID-19 vaccines under UN program
@fastcompany.com4 years ago
Nearly 25% of the world’s population may have to wait until 2022 for a COVID-19 vaccine
@theguardian.com4 years ago
Covid-19 tests that give results in minutes to be rolled out across world
@nytimesworld5 years ago
A prominent British laboratory is forming a special partnership that would sidestep the drug industry to sell a potential vaccine against the coronavirus without profits or licensing fees in Britain and in low- and middle-income countries nyti.ms
@nytimesworld5 years ago
A prominent British laboratory is forming a special partnership that would sidestep the drug industry to sell a potential vaccine against the coronavirus without profits or licensing fees in Britain and in low- and middle-income countries nyti.ms
